Exchange: NASDAQ·Updated 07:13 AM EDT

ATTO Attovia Therapeutics Inc.

$23.72
$0.02
(0.08%)
Pre-Market
Prev Close $23.70
EarningsNov 11
Mkt Cap$1.12B
Vol9.00

About ATTO

Attovia Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that creates next-generation biologic medicines for immune-mediated diseases. It was founded in 2022 and is headquartered in San Carlos, CA.
45

Neutral Sentiment

How do you feel about ATTO?

Advertisement|Remove ads.